BioTuesdays

Category - Developments

ConforMIS

BTIG cuts Conformis to neutral

BTIG downgraded Conformis (NASDAQ:CFMS) to “neutral” from “buy” following release of the company’s second quarter results. BTIG does not publish price targets on neutral-rated stocks. Conformis, which closed at $2.76 on...